Net Income

A new bispecific antibody, TRIV-573, enters clinical trials, targeting both skin barrier and inflammation to redefine atopic dermatitis therapy.

Philippine fintech giant Mynt reports a 120% quarterly profit surge, fueled by explosive growth in lending, investments, and international expansion.

Amid tourism recovery and new delivery laws, NUGL reports strong Q1 earnings, signaling a new era for Jamaica's burgeoning regulated cannabis industry.

MLP's Q1 results reveal a major strategic shift. Amid new land deals and ventures, the company's future now hinges on balancing profit with Maui's needs.

AI hardware innovator Cerebras Systems closes a massive $6.38B IPO, signaling a new front in the battle against NVIDIA with its unique wafer-scale chip.

With U.S. Army contracts and a new Texas factory, EagleNXT is pivoting to defense, adding counter-drone tech and loitering munitions to its arsenal.

A new mixed-income community in Katy leased all 93 units in record time, a stark signal of the urgent, unmet housing demand in a booming Texas region.

An American children's choir finds a second home in Shanghai, using music to build friendships and navigate complex US-China relations.

The 'AI Brain for Batteries' company takes a critical step toward going public, aiming to revolutionize energy storage and electrification via a SPAC deal.

With a new $2 billion credit line, investment fund RoboStrategy is poised to accelerate the AI robotics revolution. But can it balance growth with value?

The Tokyo-based company will issue a US$519K special dividend, a move analysts see as a bid to reward shareholders amid a slumping stock price.

As ARLP heads to a key conference, a tough quarter and a bold diversification strategy put its future in the spotlight for watchful investors.

Facing delisting, Chinese e-mobility firm EZGO enacts a drastic 1-for-150 reverse split. We explore what this means for the company and its investors.

A new report ranks Changi Airport among the world's top carbon emitters, challenging Singapore's sustainable hub ambitions amid rising global pressure.

Glucotrack seeks FDA trial approval for its revolutionary 3-year implantable glucose monitor, racing against financial clocks to change diabetes care.

Amid major Medicare policy shifts, Nuo Therapeutics reports a 169% revenue surge, positioning its Aurix wound care system as a key market disruptor.

Nubank's AI-first strategy drives record revenue and profitability in Mexico, but rising delinquencies test its advanced risk management models.

A Houston firm is set to make waves with a rare Modigliani drawing and a private Dalí painting, complete with personal letters from the artist.

Westaim posted a $33.4M Q1 loss, but strong early sales from its new annuity product suggest a long-term strategic transformation is taking root.

The Solana treasury firm reported a massive GAAP loss due to SOL's price drop, but it also secured new debt, bought back shares, and pushed into new markets.